Avalo Therapeutics AVTX Pennsylvania — Annual base rent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept avtx:LesseeOperatingLeaseAnnualBaseRent.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's pennsylvania — annual base rent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avalo Therapeutics's pennsylvania — annual base rent?
- Avalo Therapeutics (AVTX) reported pennsylvania — annual base rent of $200K in Q1 2026.
- How has Avalo Therapeutics's pennsylvania — annual base rent changed year-over-year?
- Avalo Therapeutics's pennsylvania — annual base rent decreased by 0.0% year-over-year, from $200K to $200K.
- What is the long-term trend for Avalo Therapeutics's pennsylvania — annual base rent?
- Over 3 years (2021 to 2025), Avalo Therapeutics's pennsylvania — annual base rent has grown at a -5.9% compound annual growth rate (CAGR), from $960.37K to $800K.
- What does pennsylvania — annual base rent mean?
- This metric represents the fixed annual contractual payment obligation for real estate or facility leases located within the Pennsylvania geographic segment. It reflects the core recurring cash outflow required to maintain operational infrastructure in this specific region. Monitoring this figure helps investors assess the fixed overhead burden associated with the company's physical footprint.